Anavex Life Sciences Corp (AVXL)

[indialong]

Will we get PDD results in 2019?

07/09/18: PDD P2 approved
10/30/18: First patient enrolled
03/11/19: 50% enrollment achieved (i.e., 60 patients in 132 days)

With all 18 sites now recruiting, and assuming an exponential increase in the enrollment rate due to the system getting up to speed over the last 4 months and the word about the trial getting out, it can be expected that the remaining 60 patients will be enrolled in less than the next 132 days (~ not later than July 22nd).

14 weeks of dosing beginning no later than July 22nd will be completed no later than October 28th.

That leaves at least 2 months (perhaps 3 or more) in 2019 to analyze and report the results. Not impossible.